Literature DB >> 16940101

Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Adriana Renzoni1, Christine Barras, Patrice François, Yvan Charbonnier, Elzbieta Huggler, Christian Garzoni, William L Kelley, Paul Majcherczyk, Jacques Schrenzel, Daniel P Lew, Pierre Vaudaux.   

Abstract

The molecular basis of glycopeptide-intermediate S. aureus (GISA) isolates is not well defined though frequently involves phenotypes such as thickened cell walls and decreased autolysis. We have exploited an isogenic pair of teicoplanin-susceptible (strain MRGR3) and teicoplanin-resistant (strain 14-4) methicillin-resistant S. aureus strains for detailed transcriptomic profiling and analysis of altered autolytic properties. Strain 14-4 displayed markedly deficient Triton X-100-triggered autolysis compared to its teicoplanin-susceptible parent, although microarray analysis paradoxically did not reveal significant reductions in expression levels of major autolytic genes atl, lytM, and lytN, except for sle1, which showed a slight decrease. The most important paradox was a more-than-twofold increase in expression of the cidABC operon in 14-4 compared to MRGR3, which was correlated with decreased expression of autolysis negative regulators lytSR and lrgAB. In contrast, the autolysis-deficient phenotype of 14-4 was correlated with both increased expression of negative autolysis regulators (arlRS, mgrA, and sarA) and decreased expression of positive regulators (agr RNAII and RNAIII). Quantitative bacteriolytic assays and zymographic analysis of concentrated culture supernatants showed a striking reduction in Atl-derived, extracellular bacteriolytic hydrolase activities in 14-4 compared to MRGR3. This observed difference was independent of the source of cell wall substrate (MRGR3 or 14-4) used for analysis. Collectively, our results suggest that altered autolytic properties in 14-4 are apparently not driven by significant changes in the transcription of key autolytic effectors. Instead, our analysis points to alternate regulatory mechanisms that impact autolysis effectors which may include changes in posttranscriptional processing or export.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940101      PMCID: PMC1563528          DOI: 10.1128/AAC.00113-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  110 in total

1.  Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.

Authors:  Jennifer L Koehl; Arunachalam Muthaiyan; Radheshyam K Jayaswal; Kerstin Ehlert; Harald Labischinski; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis.

Authors:  M Sugai; T Akiyama; H Komatsuzawa; Y Miyake; H Suginaka
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

3.  Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.

Authors:  J C Lucet; M Herrmann; P Rohner; R Auckenthaler; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.

Authors:  G W Kaatz; S M Seo; N J Dorman; S A Lerner
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

5.  Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Patrice Francois; Dongmei Li; William L Kelley; Daniel P Lew; Pierre Vaudaux; Jacques Schrenzel
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Isolation and characterization of autolysis-defective mutants of Staphylococcus aureus created by Tn917-lacZ mutagenesis.

Authors:  N Mani; P Tobin; R K Jayaswal
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

7.  Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus.

Authors:  H Maki; T Yamaguchi; K Murakami
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

8.  In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.

Authors:  Tanja Schneider; Maria Magdalena Senn; Brigitte Berger-Bächi; Alessandro Tossi; Hans-Georg Sahl; Imke Wiedemann
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

9.  Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex.

Authors:  D M Shlaes; J H Shlaes; S Vincent; L Etter; P D Fey; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus.

Authors:  Adhar C Manna; Susham S Ingavale; MaryBeth Maloney; Willem van Wamel; Ambrose L Cheung
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

View more
  28 in total

1.  Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA.

Authors:  Diego O Andrey; Adriana Renzoni; Antoinette Monod; Daniel P Lew; Ambrose L Cheung; William L Kelley
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

2.  The σB-dependent yabJ-spoVG operon is involved in the regulation of extracellular nuclease, lipase, and protease expression in Staphylococcus aureus.

Authors:  Bettina Schulthess; Dominik A Bloes; Patrice François; Myriam Girard; Jacques Schrenzel; Markus Bischoff; Brigitte Berger-Bächi
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

Review 3.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

4.  Physiological significance of the peptidoglycan hydrolase, LytM, in Staphylococcus aureus.

Authors:  Vineet K Singh; Mary R Carlos; Kuldeep Singh
Journal:  FEMS Microbiol Lett       Date:  2010-08-25       Impact factor: 2.742

5.  Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.

Authors:  Jean-Philippe Didier; Régis Villet; Elzbieta Huggler; Daniel P Lew; David C Hooper; William L Kelley; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

Review 6.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

7.  Genome-wide analysis of ruminant Staphylococcus aureus reveals diversification of the core genome.

Authors:  Nouri L Ben Zakour; Daniel E Sturdevant; Sergine Even; Caitriona M Guinane; Corinne Barbey; Priscila D Alves; Marie-Françoise Cochet; Michel Gautier; Michael Otto; J Ross Fitzgerald; Yves Le Loir
Journal:  J Bacteriol       Date:  2008-06-20       Impact factor: 3.490

8.  Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.

Authors:  Adriana Renzoni; William L Kelley; Christine Barras; Antoinette Monod; Elzbieta Huggler; Patrice François; Jacques Schrenzel; René Studer; Pierre Vaudaux; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

Review 9.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  A search for small noncoding RNAs in Staphylococcus aureus reveals a conserved sequence motif for regulation.

Authors:  Thomas Geissmann; Clément Chevalier; Marie-Josée Cros; Sandrine Boisset; Pierre Fechter; Céline Noirot; Jacques Schrenzel; Patrice François; François Vandenesch; Christine Gaspin; Pascale Romby
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.